PCM
VRCA icon

Pinz Capital Management’s Verrica Pharmaceuticals VRCA Stock Holding History

Pinz Capital Management’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,342
Closed -$203K – 566
2021
Q1 		$203K Buy
+1,342
New +$186K 0.05% 107

Other funds holding VRCA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Pinz Capital Management's VRCA Position: Q2 2021 in Review

Pinz Capital Management sold out of Verrica Pharmaceuticals (VRCA) in Q2 2021, closing a stake of 1,342 shares — an estimated $203K sold.

Pinz Capital Management first reported a position in VRCA in Q1 2021 and held it in 1 quarter. The position peaked at $203K in Q1 2021. 53 funds tracked by Wall St. Rank hold VRCA as of Q2 2021.

  • Pinz Capital Management reported no remaining Verrica Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Pinz Capital Management sold 1,342 Verrica Pharmaceuticals shares in Q2 2021, an estimated $203K.
  • Pinz Capital Management first reported a position in Verrica Pharmaceuticals in Q1 2021 and held it in 1 quarter.
  • Pinz Capital Management's Verrica Pharmaceuticals position peaked at $203K in Q1 2021.
  • 53 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2021.

Based on Pinz Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.